Mytos

Mytos is a biotechnology company based in London, UK, focused on developing automated infrastructure for human cell manufacturing. Founded in 2016, Mytos aims to scale regenerative medicine for widespread therapeutic use. The company operates under the legal name MYTOS BIO LIMITED and has evolved from its previous names, Cytera Cellworks and HackScience. Mytos is supported by prominent venture capitalists and participated in Y Combinator’s S18 batch. The flagship product, iDEM™, is a fully automated system that manufactures various human cell types, streamlining the traditionally labor-intensive cell culture processes. This platform allows biotech and pharmaceutical companies to grow cells on-premises while offering cloud-based monitoring and control. Mytos provides tailored automated cell manufacturing solutions for drug development, including on-premise cell culture systems and custom cell differentiation protocols. The company serves three of the top 20 global pharmaceutical companies, focusing on early-stage drug development and cell-based testing.

Research London, United Kingdom ~3 employees

Work at Mytos in HR or recruiting? Claim this page

Employees
3
0% in the 3 months to Jun 2025
12-month attrition
25%
H1B sponsor
NA
Open jobs
7
Last 30 days

Headcount trend

Mytos went from 3 employees in Jul 2023 to 3 in Jun 2025.

Headcount data through Jun 2025

Org structure

Headcount by department

Other3

Mytos FAQ

How many employees does Mytos have?

Mytos has about 3 employees, unchanged over the 3 months to Jun 2025.

Data from Company Prospectus, DOL LCA disclosures, WARN notices and 6figr salary profiles.